Skip to main content

Swiss National Bank

Bank

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1582202 ZURICH, V8

Position in ACAD

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$5,217,833
-$1,003,032 QoQ
Shares Held
234,404
+0.6% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. ACAD ranks #50 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACAD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,217,833 234,404
2025-12-31 $6,220,865 232,904
2025-09-30 $4,846,399 227,104
2025-06-30 $4,465,076 207,004
2025-03-31 $3,479,861 209,504
2024-12-31 $3,892,108 212,104
2024-09-30 $3,217,557 209,204
2024-06-30 $3,422,315 210,604
2024-03-31 $3,894,067 210,604
2023-12-31 $6,568,963 209,804
2023-09-30 $4,843,299 232,404
2023-06-30 $5,922,930 247,304
2023-03-31 $4,932,797 262,104
2022-12-31 $4,666,215 293,104
2022-09-30 $4,697,021 287,104
2022-06-30 $4,017,115 285,104
2022-03-31 $6,905,218 285,104
2021-12-31 $6,175,857 264,604
2021-09-30 $4,395,072 264,604
2021-06-30 $6,453,691 264,604
2021-03-31 $7,028,023 272,404
2020-12-31 $14,402,337 269,404
2020-09-30 $10,927,290 264,904
2020-06-30 $12,607,240 260,104
2020-03-31 $9,464,169 224,004